AMERICAN SHARED HOSPITAL SERVICES

AMS · NYSE · SIC 8071: Services-Medical Laboratories · Market Cap: $0.0B · 84 employees
337
SEC Filings
$1.47
Close 2026-07-08
7
Transcripts
84
Employees

Business Summary

American Shared Hospital Services (AMS) provides shared-service and turnkey solutions for advanced radiosurgery and radiation therapy equipment to hospitals and medical facilities. The company has a significant investment in proton beam radiation therapy business and offers capital-intensive medical equipment services. AMS operates under shared-service models, enabling healthcare providers to access high-cost treatment technology.

Latest Stock Quote

AMS 2026-07-08 $1.47 O:$1.45 H:$1.48 L:$1.41 Vol:0.1M VWAP:$1.443
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAMSdiscussed Blockchain & CryptoQ1 FY2025
topic_mentionAMSdiscussed SemiconductorQ1 FY2025
topic_mentionAMSdiscussed NetworkingQ1 FY2025
topic_mentionAMSdiscussed Capital ExpenditureQ1 FY2025
topic_mentionAMSdiscussed Supply ChainQ1 FY2025
topic_mentionAMSdiscussed RegulationQ1 FY2025
topic_mentionAMSdiscussed AutomotiveQ1 FY2025
topic_mentionAMSdiscussed Healthcare & BioQ1 FY2025
outlookAMSstated we expect tax expense in the order of 60 million EuroQ1 FY2025
outlookAMSstated We expect revenues to come in between 725 to 825 million EuroQ1 FY2025
topic_mentionAMSdiscussed Blockchain & CryptoQ2 FY2025
topic_mentionAMSdiscussed SemiconductorQ2 FY2025
topic_mentionAMSdiscussed NetworkingQ2 FY2025
topic_mentionAMSdiscussed Capital ExpenditureQ2 FY2025
topic_mentionAMSdiscussed Supply ChainQ2 FY2025
topic_mentionAMSdiscussed RegulationQ2 FY2025
topic_mentionAMSdiscussed Sovereign & GovernmentQ2 FY2025
topic_mentionAMSdiscussed AutomotiveQ2 FY2025
topic_mentionAMSdiscussed Healthcare & BioQ2 FY2025
metricAMS gross marginreported $15 percentQ2 FY2025

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001437749-26-010731EDGAR56K words
2025-04-042024-12-310001437749-25-011052EDGAR
2024-04-012023-12-310001437749-24-010308EDGAR
2023-03-312022-12-310001437749-23-008796EDGAR
2022-03-302021-12-310001437749-22-007687EDGAR
2021-04-062020-12-310000744825-21-000030EDGAR
2020-04-032019-12-310000744825-20-000024EDGAR
2019-03-292018-12-310001144204-19-016999EDGAR
2018-03-282017-12-310001144204-18-017461EDGAR
2017-03-272016-12-310001144204-17-016805EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001437749-25-035088EDGAR22K words
2025-08-132025-06-300001437749-25-026568EDGAR
2025-05-152025-03-310001437749-25-017106EDGAR
2024-11-142024-09-300001437749-24-035251EDGAR
2024-08-142024-06-300001437749-24-026762EDGAR
2024-05-152024-03-310001437749-24-017104EDGAR
2023-11-142023-09-300001437749-23-031902EDGAR
2023-08-142023-06-300001437749-23-023568EDGAR
2023-05-122023-03-310001437749-23-014203EDGAR
2022-11-102022-09-300001437749-22-026871EDGAR
2022-08-152022-06-300001437749-22-020450EDGAR
2022-05-122022-03-310001437749-22-012107EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-280001437749-26-024677EDGAR
2026-07-130001437749-26-023433EDGAR
2026-03-310001437749-26-010560EDGAR4K words
2026-03-190001437749-26-008996EDGAR
2026-01-020001437749-26-000099EDGAR
2025-12-160001437749-25-038008EDGAR
2025-11-130001437749-25-034719EDGAR
2025-08-130001437749-25-026406EDGAR
2025-07-020001437749-25-021922EDGAR
2025-06-090001437749-25-019821EDGAR

337 total filings indexed. 305 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
Q1 FY2025AMS Q1 FY2025 Earnings Call Transcript
Q2 FY2025AMS Q2 FY2025 Earnings Call Transcript
Q3 FY2025AMS Q3 FY2025 Earnings Call Transcript
Q1 FY2025AMS Q1 FY2025 Earnings Call Transcript
Q2 FY2025AMS Q2 FY2025 Earnings Call Transcript
Q3 FY2025AMS Q3 FY2025 Earnings Call Transcript
Q4 FY2025AMS Q4 FY2025 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

ACON — Aclarion, Inc. ADVB — Advanced Biomed Inc. BDSX — BIODESIX INC BLLN — BillionToOne, Inc. BGLC — BioNexus Gene Lab Corp BNR — Burning Rock Biotech Ltd CSTL — CASTLE BIOSCIENCES INC CFOR — CapForce Inc.

Tags

healthcare-/-hospital-services radiation-therapy radiosurgery proton-beam-therapy

Company Identity

CIK0000744825
TickerAMS
ExchangeNYSE
SIC8071: Services-Medical Laboratories
IncorporatedCA
Websitehttps://www.ashs.com
Listed1984-09-07

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 19100a78ba863d63c4f937bd5235ef623dee49f61731b0cbb60b2844c49f7a45
parent: d0253f7a5da037050d098e10c982509cbcc40728f297b06e3dd59ec6fc059a20
content hash: a0d929dcae55b58d1abc095697889c1f9c4b6ceadb41e83c888046c899750eec
signed: 2026-08-10T19:00:46.764Z
sources: 29 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AMS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AMS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AMS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.